Suneet Pandey has been Global Technology Procurement & Supplier Governance manager at Lonza since 2017. In his position, he has been responsible for the Global Technology Procurement & Supplier governance across business functions; defining and driving procurement strategies for services, software and telecom in alignment with internal use cases; assuming full accountability for market interaction, negotiations and contract execution; supporting CXOs in establishing supplier relationships and collaboratively defining technology roadmap; identifying and delivering value (cost avoidance, savings, Buy vs Make decisions) based on market expertise, relationships and keeping abreast with the new technologies and service models; and managing the annual Capex and Opex budget and propose supplier risk mitigation strategies.

Lonza is the preferred global partner to the pharmaceutical, biotech and nutrition markets. We focus on enabling treatments that prevent illness and support healthier lifestyles. We optimize scientific innovation and manufacturing technology to enable our customers to serve their patients and consumers. We provide a wide range of services and products from early phase discovery to custom development and manufacturing of active pharmaceutical ingredients to innovative dosage forms for the pharma and consumer health and nutrition industries. Our scale and resources mean we can provide a one-stop solution for our customers to help people get well, feel well, and stay well. In 2020, we supported more than 820 preclinical and clinical small and large molecules, more than 245 commercial small and large molecules and produced 230 billion capsules. Founded in 1897 in the Swiss Alps, today, Lonza operates across five continents. With approximately 15,000 employees, we comprise high-performing teams and individual talent that make a meaningful difference to our own business, as well as to the communities in which we operate. Our business benefits from global supply chains, but we have worked to maintain the agility to address marketplace needs on a local level. Lonza generated sales of CHF 2.5 billion with a CORE EBITDA of CHF 847 million in H1 2021.